Beauty Health Q1 2024 GAAP EPS $(0.10) Beats $(0.14) Estimate, Sales $81.400M Beat $80.533M Estimate
Portfolio Pulse from Benzinga Newsdesk
Beauty Health (NASDAQ:SKIN) reported Q1 2024 earnings with a smaller loss per share of $(0.10) compared to the expected $(0.14), and sales of $81.4M, surpassing the forecast of $80.533M. Despite beating estimates, sales decreased by 5.68% from the previous year.
May 09, 2024 | 9:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Beauty Health reported a smaller than expected Q1 2024 loss and higher sales, beating analyst estimates but with a year-over-year sales decline.
The positive earnings surprise, with both EPS and sales beating estimates, typically leads to a favorable short-term stock price reaction. However, the year-over-year decline in sales might temper investor enthusiasm, suggesting a cautious optimism for the stock's short-term trajectory.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100